Calnexin or CANX is an ER stress chaperone transmembrane protein involved in glycoprotein folding, is considered a prognostic indicator and therapeutic target in CRC [25], and is found to restrict antitumor CD4+ and CD8+ T cells [26] in oral cancer. This evidence concerns the gene CD4 and lip and oral cavity carcinoma.